A treatment algorithm for the management of chronic hepatitis B virus infection in the United States
- 1 February 2004
- journal article
- review article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 2 (2), 87-106
- https://doi.org/10.1016/s1542-3565(03)00312-4
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- Resistance surveillance of HBEAG— chronic hepatitis B (CHB) patients treated for two years with adefovir dipivoxil (ADV)Journal of Hepatology, 2003
- EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B13–14 September, 2002Geneva, SwitzerlandJournal of Hepatology, 2003
- Ribavirin and Interferon Is Effective for Hepatitis C Virus Clearance in Hepatitis B and C Dually Infected PatientsHepatology, 2003
- Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infectionHepatology, 2002
- The long-term outcome of interferon-α treated and untreated patients with HBeAg-negative chronic hepatitis BJournal of Hepatology, 2001
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoproteinJournal of Hepatology, 1994
- Treatment algorithms for hepatitis B and C.Gut, 1993
- Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infectionJournal of Hepatology, 1990
- Which Patients With Chronic Hepatitis B Virus Infection Will Respond to α–Interferon Therapy? A Statistical Analysis of Predictive FactorsHepatology, 1989